Blueberry Nirman Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.66 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 66.78%
- Profit Growth -314.65%
- Ebitda -74.85%
- Net Worth -1.43%
- Total Assets -5.64%
About Blueberry Nirman
Blueberry Nirman Private Limited (BNPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 2008 and has a history of 16 years and seven months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.66 M, as per Ministry of Corporate Affairs (MCA) records.
Sukesh Agarwal and Durga Agarwala serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U70109WB2008PTC126987
-
Company No.
126987
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jun 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Blueberry Nirman?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukesh Agarwal
|
Additional Director | 24-Dec-2014 | Current |
|
Durga Agarwala
|
Additional Director | 24-Dec-2014 | Current |
Financial Performance of Blueberry Nirman.
Blueberry Nirman Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 66.78% increase. The company also saw a substantial fall in profitability, with a 314.65% decrease in profit. The company's net worth dipped by a decrease of 1.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blueberry Nirman?
In 2019, Blueberry Nirman had a promoter holding of 3.82% and a public holding of 96.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Midnapore Diagnostics Private LimitedSukesh Agarwal is a mutual person
-
Mediseba Healthcare LimitedSukesh Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blueberry Nirman?
Unlock and access historical data on people associated with Blueberry Nirman, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blueberry Nirman, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blueberry Nirman's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
